Sai Life Sciences has announced that a meeting of the Board of Directors will be held on Thursday, 5th February 2026, to consider and approve the Un-audited Financial Results (Standalone and Consolidated) for the Third Quarter and Nine Months ended 31 December 2025. The trading window has been closed from 01 January, 2026 and will remain closed until 48 hours after the declaration of the results.
Board Meeting Announcement
A meeting of the Board of Directors of Sai Life Sciences is scheduled for Thursday, 5th February 2026. The primary purpose of this meeting is to review and approve the company’s financial performance for the third quarter of the fiscal year.
Agenda: Q3 & 9-Month Financial Results
The Board will specifically focus on the Un-audited Financial Results (Standalone and Consolidated) for the Third Quarter (Q3: October-December) and the nine-month period ending 31 December 2025.
Trading Window Closure
In accordance with company policy, the trading window for dealing in the company’s securities has been closed since 01 January, 2026. This closure will remain in effect until 48 hours following the public release of the financial results. This measure is designed to ensure fairness and prevent any potential misuse of inside information.
Source: BSE
